DiaSys Announces Strategic Distribution Partner In China; Receives Initial Order For 60 Workstations.WATERBURY, Conn.--(BUSINESS WIRE)-- DiaSys Corporation (NASD NASD See: National Association of Securities Dealers NASD See National Association of Securities Dealers (NASD). :DIYS) today announced that it has entered into a multi-year sales and service agreement with Hua Sin Science Co. LTD LTD 1 Laron-type dwarfism 2 Leukotriene D 3 Long-term depression, see there 4. Long-term disability , located in Guangzhou China. Hua Sin manufactures and distributes instruments and reagents to China's 60,000 hospital and medical laboratories. Hua Sin is also the exclusive distributor of BAYER's CLINITEK series urine chemistry analyzers in China. DiaSys further reported that the parties officially commenced joint operations A general term to describe military actions conducted by joint forces or by Service forces in relationships (e.g., support, coordinating authority) which, of themselves, do not create joint forces. last week in Guangzhou, and in that connection Hua Sin has ordered sixty (60) R/S R/S Remote Sensing R/S Rally Sport R/S Respectfully Submit R/S Report of Survey R/S Route Sheet R/S Reentry System R/S Revision Segment R/S Rationalization & Standardization R/S Regulatory or Safety (automotive requirements) 2003 urine sediment workstations. Albert Luo, Hua Sin's General Manager, said that Chinese laboratory medicine is increasingly focused on higher accuracy and better cost efficiency. He said that the Chinese Committee For Clinical Laboratory Standards (CCCLS) has also adopted a number of guidelines to standardize the way in which tests are conducted among all laboratories, including urinalysis. Mr. Luo said that the combination of Bayer and DiaSys urine instruments is an ideal solution to clinical laboratory needs of accuracy, quality control, and cost efficiency. Todd M. DeMatteo, President/CEO of DiaSys, said that the combination of BAYER's CLINITEK analyzers and DiaSys "R/S" urine sediment workstations is becoming very popular in the United States. He said that while specific priorities may differ among countries, the overlying overlying suffocation of piglets by the sow. The piglets may be weak from illness or malnutrition, the sow may be clumsy or ill, the pen may be inadequate in size or poorly designed so that piglets cannot escape. need is always the same: test accuracy, traceable quality control and cost efficiency. DeMatteo said that Hua Sin will be a strong and articulate proponent of the Bayer/DiaSys solution in China. Hua Sin Science Co. employs 220 people in China, 120 of whom are engaged in sales, marketing and service. Hua Sin also has 18 sales offices located throughout China. DiaSys Corporation designs, develops, manufactures and distributes medical laboratory equipment with applications in urinalysis, microbiology and cytology cytology (sītŏl`əjē), in biology, the study of the structure of all normal and abnormal components of cells and the changes, movements, and transformations of such components. . CLINITEK is a registered trademark of BAYER. DiaSys is a registered trademark of DiaSys Corporation. The foregoing press release includes "forward looking statements" within the meaning of and made pursuant to the safe harbor Safe Harbor 1. A legal provision to reduce or eliminate liability as long as good faith is demonstrated. 2. A form of shark repellent implemented by a target company acquiring a business that is so poorly regulated that the target itself is less attractive. provisions of the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995. Such forward looking statements involve known and unknown risks, uncertainties, and other factors which may cause the actual results, performance or achievements of the Company to materially differ from those expressed or implied by such forward looking statements. DiaSys refers interested parties to its most recent Annual Report on form 10-KSB and other SEC filings for a complete description of and discussion about the company. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion